Tropical spastic paraparesis/human T-cell leukemia type I-associated myelopathy (TSP/HAM) is caused by a human T-cell leukemia virus type I (HTLV-I) after a long incubation period. TSP/HAM is characterized by a chronic progressive paraparesis with sphincter disturbances, no/mild sensory loss, the absence of spinal cord compression and seropositivity for HTLV-I antibodies. The pathogenesis of this entity is not completely known and involves a multivariable phenomenon of immune system activation against the presence of HTLV-I antigens, leading to an inflammatory process and demyelination, mainly in the thoracic spinal cord. The current hypothesis about the pathogenesis of TSP/HAM is: 1) presence of HTLV-I antigens in the lumbar spinal cord, noted by an increased DNA HTLV-I load; 2) CTL either with their lytic functions or release/production of soluble factors, such as CC-chemokines, cytokines, and adhesion molecules; 3) the presence of Tax gene expression that activates T-cell proliferation or induces an inflammatory process in the spinal cord; 4) the presence of B cells with neutralizing antibody production, or complement activation by an immune complex phenomenon, and 5) lower IL-2 and IFN-γ production and increased IL-10, indicating drive to a cytokine type 2 pattern in the TSP/HAM subjects and the existence of a genetic background such as some HLA haplotypes. All of these factors should be implicated in TSP/HAM and further studies are necessary to investigate their role in the development of TSP/HAM.331213951401Aboulafia, D.M., Clinical implications of human T-cell leukemia virus type I/II-associated diseases (1995) AIDS Reader, 5, pp. 118-125Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., Uchino, H., Adult T-cell leukemia: Clinical and hematologic features of 16 cases (1977) Blood, 50, pp. 481-492Osame, M., Janssen, R., Kubota, H., Nishitani, H., Igata, A., Nagataki, S., Mori, M., Khabbaz, R., Nationwide survey of HTLV-I-associated myelopathy in Japan: Association with blood transfusion (1990) Annals of Neurology, 28, pp. 50-56Gessain, A., Barin, F., Vernant, J.C., Gout, O., Maurs, L., Calender, A., De The, G., Antibodies to human T-lyrnphotropic virus type-I in patients with tropical spastic paraparesis (1985) Lancet, 2, pp. 407-410Osame, M., Usuku, J., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., Tara, M., HTLV-I-associated myelopathy: A new clinical entity (1985) Lancet, 1, pp. 1031-1032Gessain, A., Gout, O., Chronic myelopathy with human T-lymphotropic virus type I (HTLV-I) (1992) Annals of Internal Medicine, 117, pp. 933-946Iwasaki, Y., Pathology of chronic myelopathy associated with HTLV-I infection (TSP/HAM) (1990) Journal of Neurological Sciences, 96, pp. 103-123Seiki, M., Hattori, S., Hirayama, Y., Yoshida, M., Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA (1983) Proceedings of the National Academy of Sciences, USA, 80, pp. 3618-3622Murphy, E.L., Blattner, W.A., HTLV-I-associated leukemia: A model for chronic retroviral diseases (1988) Annals of Neurology, 23, pp. S174-S180Piccardo, P., Ceroni, M., Rodgers-Johnson, P., Mora, C., Asher, D.M., Char, G., Gibbs C.J., Jr., Gajdusek, D.C., Pathological and immunological observations on tropical spastic paraparesis in patients from Jamaica (1988) Annals of Neurology, 23, pp. 156-160Azizuki, S., Nakasato, O., Higuchi, Y., Tanabe, K., Setoguchi, M., Yoshida, S., Miyazaki, Y., Okajima, T., Necropsy findings in HTLV-I associated myelopathy (1987) Lancet, 1, pp. 156-157Tendler, G.L., Greenberg, S.J., Blattner, W.A., Manns, A., Murphy, E., Fleisher, T., Hanchard, B., Waldmann, T.A., Transactivation of mterleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: Pathogenic implications and a rationale for immunotherapy (1990) Proceedings of the National Academy of Sciences, USA, 87, pp. 5218-5222Cheng, H., Tranok, J., Parks, W.P., Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 tax protein is through cooperation of NF-kB and tat (1998) Journal of Virology, 72, pp. 6911-6916Gessain, A., Saal, F., Gout, O., Daniel, M.T., Flandrin, G., De The, G., Peries, J., Sigaux, F., High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis (1990) Blood, 75, pp. 428-433Nagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, T.M., Hashiguchi, S., Ichinose, M., Osame, M., Analysis of HTLV-I proviral load in 202 TSP/HAM patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to TSP/HAM (1998) Journal of Neurovirology, 4, pp. 586-593Manns, A., Miley, J.W., Wilks, J.R., Morgan, O.C., Hanchard, B., Warfe, G., Cranston, B., Waters, D., Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection (1999) Journal of Infectious Diseases., 180, pp. 1487-1493Hara, H., Autoimmune mechanism in TSP/HAM (1994) Nippon Rinsho, 52, pp. 2919-2925Levin, M.C., Krichavsky, M., Berk, J., Foley, S., Rosenfeld, M., Dalmau, J., Chang, G., Jacobson, S., Neuronal molecular mimicry in immune-mediated neurologic disease (1998) Annals of Neurology, 44, pp. 87-98Hoffman, T.L., Doms, R.W., Chemokines and coreceptors in HIV/SIV-host interactions (1998) AIDS, 12 (SUPPL. A), pp. S17-S26Copeland, K.F.T., Heeney, J.L., T helper cell activation and human retroviral pathogenesis (1996) Microbiological Reviews, 60, pp. 722-742Oliva, A., Kinter, A.L., Vaccarezza, M., Rubbert, A., Catanzaro, A., Mo'r, S., Monaco, J., Fauci, A.S., Natural killer cells from human immunodeficiency virus (HIV)-in-fected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro (1998) Journal of Clinical Investigation, 102, pp. 223-231Umehara, F., Izumo, S., Takeya, M., Takahashi, K., Sato, E., Osame, M., Expression of adhesion molecules and monocyte chemcattractant protem-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy (1996) Acta Neuropathologica, 91, pp. 343-350Giraudon, P., Buart, S., Bernard, A., Belin, M.F., Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes (1997) Molecular Psychiatry, 2, pp. 107-110Greten, T.F., Slansky, J.E., Kubota, R., Soldan, S.S., Jaffee, E.M., Leist, T.P., Pardoll, D.M., Schneck, J.P., Direct visualization of antigen-specific T cells: HTLV-1 Taxi11-19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from TSP/ HAM patients (1998) Proceedings of the National Academy of Sciences, USA, 95, pp. 7568-7573Biddison, W.E., Kubota, R., Kawanishi, T., Taub, D.D., Cruikshank, W.W., Center, D.M., Connor, E.W., Jacobson, S., Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokmes, and matrix metalloproteinase (1997) Journal of Immunology, 159, pp. 2018-2025Hoffman, P.M., Dhib-Jalbut, S., Mikovits, J.A., Robbins, D.S., Wolf, A.L., Bergey, G.K., Lohrey, N.C., Ruscetti, F.W., Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures (1992) Proceedings of the National Academy of Sciences, USA, 89, pp. 11784-11788Fox, R.J., Levin, M.C., Jacobson, S., Tumor necrosis factor alpha expression in the spinal cord of human T-cell lymphotrophic virus type I associated myelopathy/tropical spastic paraparesis patients (1996) Journal of Neurovirology, 2, pp. 323-329Nagai, M., Ijichi, S., Hall, W.W., Osame, M., Differential effect of TGF-beta 1 on the in vitro activation of HTLV-I and the proliferates response of CDS+ T lymphocytes in patients with HTLV-I-associated myelopathy (TSP/HAM) (1995) Clinical Immunology and Immunopathology, 77, pp. 324-331Saarloos, M.N., Koenig, R.E., Spear, G.T., Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus HTLVI with HTLV-I-associated myelopathy/tropical spastic paraparesis (1995) Journal of Infectious Diseases, 172, pp. 1095-1097Lira, J., Nakamura, M., Sawada, Y., Ohori, N., Itoyama, Y., Yamamoto, N., Sakaki, Y., Goto, I., Antibody titers to HTLV-Ip40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: Correlation with increased HTLV-I proviral DNA load (1992) Journal of Neurological Sciences, 107, pp. 98-104Usuku, K., Sonoda, S., Osame, M., Yashiki, S., Takahashi, K., Matsumoto, M., Sawada, T., Igata, A., HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma (1988) Annals of Neurology, 23, pp. 143-150Godoy, A.J., Itoyama, Y., Tokunaga, K., Hara, H., Kawaga, Y., Kiyokawa, H., Maeda, Y., Goto, I., Allolymphocytotoxic antibodies in sera from HTLV-I-associated myelopathy/tropical spastic paraparesis patients-putative anti-HLA antibodies (1994) Journal of Neurological Sciences, 125, pp. 62-69Uchiyama, T., Human T cell leukemia virus type I (HTLV-I) and human diseases (1997) Annual Review of Immunology, 15, pp. 15-37Manns, A., Hanchard, B., Morgan, O.S., Wilks, R., Cranston, B., Nam, J.M., Blank, M., Sonoda, S., Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/ lymphoma in a Black population (1998) Journal of the National Cancer Institute, 90, pp. 617-622Jeffery, K.J.M., Usuku, K., Hall, S.E., Matsumoto, W., Taylor, G.P., Procter, J., Bunce, M., Bangham, C.R.M., HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy (1999) Proceedings of the National Academy of Sciences, USA, 96, pp. 3848-3853Bangham, C.R.M., Kermode, A.L., Hall, S.E., Daenke, S., The cytotoxic T-lymphocyte response to HTLV-I: The main determinant of disease? (1996) Seminars in Virology, 7, pp. 41-48Höllsberg, P., Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I (1997) Acta Neurologica Scandinavica, 169 (SUPPL.), pp. 86-93Elovaara, I., Koenig, S., Brewah, A.Y., Woods, R.M., Lehky, T., Jacobson, S., High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease (1993) Journal of Experimental Medicine, 177, pp. 1567-1573Casseb, J., Hong, M.A., Salomão, S., Duarte, A.J.S., Gallo, D., Hendry, R.M., Comfection with human immunodeficiency virus and human T-cell lymphotropic virus type I: Reciprocal activation with clinical and immunological consequences (1997) Clinical Infectious Diseases, 25, pp. 1259-1260Casseb, J., Is HTLV-I more clever than HIV-I? (1998) Clinical Infectious Diseases, 27, pp. 1309-131
